Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiping Feng

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Circulation|April 29, 2018
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving StatinsWei-Qi Wei, Xiaohui Li, Qiping Feng, et al.
Plos Genetics|April 14, 2020
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.
Plos Genetics|April 6, 2021
Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.
Nature Communications|September 1, 2018
A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkersJonathan D Mosley, QiPing Feng, Quinn S Wells, et al.
Wellcome Open Research|September 2, 2024
Genome-wide association study of susceptibility to hospitalised respiratory infectionsAlexander T Williams, Nick Shrine, Hardeep Naghra-van Gijzel, et al.
Plos Genetics|April 1, 2020
Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) studyYao Hu, Mariaelisa Graff, Jeffrey Haessler, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Selection, optimization, and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Medicine|February 20, 2024
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Circulation|April 29, 2018
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving StatinsWei-Qi Wei, Xiaohui Li, Qiping Feng, et al.
Plos Genetics|April 14, 2020
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.
Plos Genetics|April 6, 2021
Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.
Nature Communications|September 1, 2018
A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkersJonathan D Mosley, QiPing Feng, Quinn S Wells, et al.
Wellcome Open Research|September 2, 2024
Genome-wide association study of susceptibility to hospitalised respiratory infectionsAlexander T Williams, Nick Shrine, Hardeep Naghra-van Gijzel, et al.
Plos Genetics|April 1, 2020
Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) studyYao Hu, Mariaelisa Graff, Jeffrey Haessler, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Selection, optimization, and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Medicine|February 20, 2024
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
Pageof 12